Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Substituted phenidates

From PsychonautWiki Archive
Revision as of 15:42, 5 September 2017 by >Unity (Add citation. Add 'Literature' and 'References' sections.)
Jump to navigation Jump to search
Generic structure of a phenidate molecule.

Substituted phenidates (also known as phenidates) are a class of chemicals that include compounds that predominantly produce traditional stimulant effects when administered. They may be defined as esters of ritalinic acid and its analogs.

Chemistry

Substituted phenidates are a chemical class based upon the molecule methylphenidate. The molecular structure of methylphenidate is comprised of a phenethylamine core with a carbon chain substitution at the Rα position that links to the RN position, forming a piperidine ring. It also includes a substitution at the Rβ position of methyl acetate.

Pharmacology

This pharmacology section is incomplete.

You can help by adding to it.

Substituted phenidates primarily act as reuptake inhibitors of the monoamine neurotransmitters dopamine, norepinephrine, and to a much lesser degree, serotonin. One study found that all substituted phenidates inhibited the norepinephrine and dopamine reuptake transporters 4 to >1,000-fold more potently than the serotonin transporter.[1]

List of substituted phenidates

Compound R3 R4 RO Structure
Methylphenidate H H CH3
Ethylphenidate H H CH2CH3
Isopropylphenidate H H CH(CH3)2
Propylphenidate H H CH2CH2CH3
4-Methylmethylphenidate H CH3 CH3
3,4-CTMP Cl Cl CH3
4F-MPH H F CH3
4F-EPH H F CH2CH3
Methylnaphthidate (HDMP-28) CH=CH- CH=CH- CH3
Ethylnaphthidate (HDEP-28) CH=CH- CH=CH- CH2CH3

See also

Literature

References

  1. Luethi, D., Kaeser, P. J., Brandt, S. D., Krähenbühl, S., Hoener, M. C., & Liechti, M. E. (2017). Pharmacological profile of methylphenidate-based designer drugs. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2017.08.020